FDA 483 - Polarean, Inc. - September 07, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Polarean Inc. in Durham, NC, a combo drug/device manufacturer, was inspected by the FDA from August 30 to September 7, 2021. The inspection revealed a significant issue with design validation, specifically that the hyperpolarizer device was not validated using production-equivalent units. Furthermore, changes made to the device and a change in contract manufacturer were not properly documented or re-evaluated, indicating potential deficiencies in quality system controls for device design and manufacturing.
ID · 835f737f-fef4-4bfa-bd44-046f32a5d692